Ben Tre Pharmaceutical JSC (HOSE:DBT)
10,350
+100 (0.98%)
At close: Feb 9, 2026
HOSE:DBT Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Cash & Equivalents | 20,851 | 7,863 | 20,648 | 33,102 | 45,956 |
Short-Term Investments | 1,164 | - | - | 49,000 | 37,181 |
Trading Asset Securities | 39,493 | 39,493 | 39,493 | - | - |
Cash & Short-Term Investments | 61,508 | 47,356 | 60,141 | 82,102 | 83,136 |
Cash Growth | 29.89% | -21.26% | -26.75% | -1.24% | -21.26% |
Accounts Receivable | 229,970 | 168,118 | 170,555 | 132,844 | 153,568 |
Other Receivables | 661.6 | 799.92 | 1,150 | 12,189 | 21,875 |
Receivables | 241,632 | 179,918 | 191,705 | 145,033 | 175,444 |
Inventory | 422,204 | 470,128 | 355,921 | 279,794 | 174,022 |
Prepaid Expenses | 1,703 | 2,082 | 1,617 | 631.51 | 1,402 |
Other Current Assets | 31,859 | 42,851 | 79,528 | 17,255 | 9,919 |
Total Current Assets | 758,906 | 742,335 | 688,912 | 524,815 | 443,922 |
Property, Plant & Equipment | 112,293 | 124,289 | 66,622 | 81,384 | 85,170 |
Long-Term Investments | - | - | 39,768 | 50,978 | 54,467 |
Goodwill | 30,322 | 34,383 | 903.27 | 4,844 | 6,137 |
Other Intangible Assets | 5,662 | 6,847 | 7,388 | 4,002 | 4,306 |
Long-Term Deferred Tax Assets | 13,282 | 12,738 | 10,942 | - | 1,187 |
Other Long-Term Assets | 69,552 | 73,164 | 41,072 | 33,792 | 22,206 |
Total Assets | 990,017 | 993,757 | 855,608 | 699,815 | 617,395 |
Accounts Payable | 94,868 | 117,197 | 83,814 | 124,933 | 130,527 |
Accrued Expenses | 40,108 | 30,514 | 34,049 | 3,852 | 9,271 |
Short-Term Debt | 520,501 | 501,163 | 458,737 | 314,867 | 221,180 |
Current Portion of Long-Term Debt | 6,866 | 7,556 | 4,693 | - | - |
Current Portion of Leases | 6,373 | 7,092 | 1,684 | - | - |
Current Income Taxes Payable | 9,353 | 9,340 | 10,037 | 4,407 | 4,750 |
Current Unearned Revenue | 521.99 | 489.38 | 272.66 | 180 | 163.64 |
Other Current Liabilities | 1,586 | 2,376 | 3,066 | 1,953 | 11,327 |
Total Current Liabilities | 680,178 | 675,728 | 596,352 | 450,191 | 377,218 |
Long-Term Debt | 11,846 | 19,806 | 8,335 | 11,461 | - |
Long-Term Leases | 3,079 | 9,421 | 2,966 | - | - |
Long-Term Unearned Revenue | 1,582 | 1,976 | - | - | - |
Long-Term Deferred Tax Liabilities | 2,654 | 2,721 | - | 597.52 | 280.34 |
Other Long-Term Liabilities | 70.44 | 70.44 | 70.44 | 130.5 | 93 |
Total Liabilities | 699,408 | 709,724 | 607,723 | 462,380 | 377,592 |
Common Stock | 219,673 | 205,307 | 163,255 | 135,288 | 123,145 |
Additional Paid-In Capital | 383.06 | 383.06 | 523.06 | 433.06 | 538.06 |
Retained Earnings | 49,765 | 57,168 | 73,551 | 42,986 | 43,273 |
Comprehensive Income & Other | 2,587 | 2,587 | 2,587 | 2,587 | 2,587 |
Total Common Equity | 272,408 | 265,444 | 239,916 | 181,294 | 169,542 |
Minority Interest | 18,201 | 18,589 | 7,969 | 56,141 | 70,261 |
Shareholders' Equity | 290,609 | 284,033 | 247,885 | 237,435 | 239,804 |
Total Liabilities & Equity | 990,017 | 993,757 | 855,608 | 699,815 | 617,395 |
Total Debt | 548,666 | 545,039 | 476,414 | 326,328 | 221,180 |
Net Cash (Debt) | -487,157 | -497,683 | -416,273 | -244,226 | -138,044 |
Net Cash Per Share | -22176.52 | -26633.96 | -24497.94 | - | - |
Filing Date Shares Outstanding | 21.97 | 21.97 | 16.99 | - | - |
Total Common Shares Outstanding | 21.97 | 21.97 | 16.99 | - | - |
Working Capital | 78,729 | 66,607 | 92,560 | 74,624 | 66,704 |
Book Value Per Share | 12400.63 | 12083.34 | 14119.20 | - | - |
Tangible Book Value | 236,425 | 224,214 | 231,624 | 172,448 | 159,100 |
Tangible Book Value Per Share | 10762.59 | 10206.47 | 13631.23 | - | - |
Buildings | 102,960 | 103,327 | 62,220 | - | - |
Machinery | 85,522 | 85,178 | 67,936 | - | - |
Construction In Progress | 755.96 | 482.5 | 7,759 | 2,000 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.